BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 15522275)

  • 1. Genetic enhancement of ventricular contractility protects against pressure-overload-induced cardiac dysfunction.
    Du XJ; Fang L; Gao XM; Kiriazis H; Feng X; Hotchkin E; Finch AM; Chaulet H; Graham RM
    J Mol Cell Cardiol; 2004 Nov; 37(5):979-87. PubMed ID: 15522275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transgenic alpha1A-adrenergic activation limits post-infarct ventricular remodeling and dysfunction and improves survival.
    Du XJ; Gao XM; Kiriazis H; Moore XL; Ming Z; Su Y; Finch AM; Hannan RA; Dart AM; Graham RM
    Cardiovasc Res; 2006 Sep; 71(4):735-43. PubMed ID: 16859660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct role of adrenoceptor subtypes in cardiac adaptation to chronic pressure overload.
    Du XJ
    Clin Exp Pharmacol Physiol; 2008 Mar; 35(3):355-60. PubMed ID: 18290877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sustained augmentation of cardiac alpha1A-adrenergic drive results in pathological remodeling with contractile dysfunction, progressive fibrosis and reactivation of matricellular protein genes.
    Chaulet H; Lin F; Guo J; Owens WA; Michalicek J; Kesteven SH; Guan Z; Prall OW; Mearns BM; Feneley MP; Steinberg SF; Graham RM
    J Mol Cell Cardiol; 2006 Apr; 40(4):540-52. PubMed ID: 16516910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse effects of constitutively active alpha(1B)-adrenergic receptors after pressure overload in mouse hearts.
    Wang BH; Du XJ; Autelitano DJ; Milano CA; Woodcock EA
    Am J Physiol Heart Circ Physiol; 2000 Sep; 279(3):H1079-86. PubMed ID: 10993770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of survival signalling pathways and increased apoptosis in the transition of pressure overload-induced cardiac hypertrophy to heart failure.
    Li XM; Ma YT; Yang YN; Liu F; Chen BD; Han W; Zhang JF; Gao XM
    Clin Exp Pharmacol Physiol; 2009 Nov; 36(11):1054-61. PubMed ID: 19566828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of mTOR reduces chronic pressure-overload cardiac hypertrophy and fibrosis.
    Gao XM; Wong G; Wang B; Kiriazis H; Moore XL; Su YD; Dart A; Du XJ
    J Hypertens; 2006 Aug; 24(8):1663-70. PubMed ID: 16877971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RGS4 causes increased mortality and reduced cardiac hypertrophy in response to pressure overload.
    Rogers JH; Tamirisa P; Kovacs A; Weinheimer C; Courtois M; Blumer KJ; Kelly DP; Muslin AJ
    J Clin Invest; 1999 Sep; 104(5):567-76. PubMed ID: 10487771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted alpha(1A)-adrenergic receptor overexpression induces enhanced cardiac contractility but not hypertrophy.
    Lin F; Owens WA; Chen S; Stevens ME; Kesteven S; Arthur JF; Woodcock EA; Feneley MP; Graham RM
    Circ Res; 2001 Aug; 89(4):343-50. PubMed ID: 11509451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of endogenous Mst1 prevents apoptosis and cardiac dysfunction without affecting cardiac hypertrophy after myocardial infarction.
    Odashima M; Usui S; Takagi H; Hong C; Liu J; Yokota M; Sadoshima J
    Circ Res; 2007 May; 100(9):1344-52. PubMed ID: 17395874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pressure overload induces greater hypertrophy and mortality in female mice with p38alpha MAPK inhibition.
    Liu J; Sadoshima J; Zhai P; Hong C; Yang G; Chen W; Yan L; Wang Y; Vatner SF; Vatner DE
    J Mol Cell Cardiol; 2006 Oct; 41(4):680-8. PubMed ID: 16928383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel contractile phenotype with cardiac transgenic expression of the human P2X4 receptor.
    Hu B; Mei QB; Yao XJ; Smith E; Barry WH; Liang BT
    FASEB J; 2001 Dec; 15(14):2739-41. PubMed ID: 11606481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective role of endogenous erythropoietin system in nonhematopoietic cells against pressure overload-induced left ventricular dysfunction in mice.
    Asaumi Y; Kagaya Y; Takeda M; Yamaguchi N; Tada H; Ito K; Ohta J; Shiroto T; Shirato K; Minegishi N; Shimokawa H
    Circulation; 2007 Apr; 115(15):2022-32. PubMed ID: 17404160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of adenosine A1 receptor attenuates cardiac hypertrophy and prevents heart failure in murine left ventricular pressure-overload model.
    Liao Y; Takashima S; Asano Y; Asakura M; Ogai A; Shintani Y; Minamino T; Asanuma H; Sanada S; Kim J; Ogita H; Tomoike H; Hori M; Kitakaze M
    Circ Res; 2003 Oct; 93(8):759-66. PubMed ID: 12970111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of the nicotinamide adenosine dinucleotide phosphate oxidase isoform Nox2 in cardiac contractile dysfunction occurring in response to pressure overload.
    Grieve DJ; Byrne JA; Siva A; Layland J; Johar S; Cave AC; Shah AM
    J Am Coll Cardiol; 2006 Feb; 47(4):817-26. PubMed ID: 16487851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen receptor beta protects the murine heart against left ventricular hypertrophy.
    Babiker FA; Lips D; Meyer R; Delvaux E; Zandberg P; Janssen B; van Eys G; Grohé C; Doevendans PA
    Arterioscler Thromb Vasc Biol; 2006 Jul; 26(7):1524-30. PubMed ID: 16627800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitric oxide synthase 2 and pressure-overload-induced left ventricular remodelling in mice.
    Hataishi R; Rodrigues AC; Morgan JG; Ichinose F; Derumeaux G; Bloch KD; Picard MH; Scherrer-Crosbie M
    Exp Physiol; 2006 May; 91(3):633-9. PubMed ID: 16527862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pressure overload causes cardiac hypertrophy in beta1-adrenergic and beta2-adrenergic receptor double knockout mice.
    Palazzesi S; Musumeci M; Catalano L; Patrizio M; Stati T; Michienzi S; Di Certo MG; Mattei E; Vitelli L; Marano G
    J Hypertens; 2006 Mar; 24(3):563-71. PubMed ID: 16467660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concentric left ventricular remodeling in endothelial nitric oxide synthase knockout mice by chronic pressure overload.
    Ruetten H; Dimmeler S; Gehring D; Ihling C; Zeiher AM
    Cardiovasc Res; 2005 Jun; 66(3):444-53. PubMed ID: 15914109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Morphological and functional alterations in ventricular myocytes from male transgenic mice with hypertrophic cardiomyopathy.
    Olsson MC; Palmer BM; Stauffer BL; Leinwand LA; Moore RL
    Circ Res; 2004 Feb; 94(2):201-7. PubMed ID: 14670849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.